Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 642

1.

Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab.

Vallejo-Vaz AJ, Leiter LA, Del Prato S, Taskinen MR, Müller-Wieland D, Bujas-Bobanovic M, Letierce A, Mandel J, Samuel R, Ray KK.

Eur J Prev Cardiol. 2020 Feb 23:2047487320905185. doi: 10.1177/2047487320905185. [Epub ahead of print]

PMID:
32089006
2.

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN.

Eur Heart J. 2020 Feb 13. pii: ehz962. doi: 10.1093/eurheartj/ehz962. [Epub ahead of print] No abstract available.

PMID:
32052833
3.

Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects.

Taskinen MR, Björnson E, Andersson L, Kahri J, Porthan K, Matikainen N, Söderlund S, Pietiläinen K, Hakkarainen A, Lundbom N, Nilsson R, Ståhlman M, Adiels M, Parini P, Packard C, Borén J.

J Clin Lipidol. 2019 Dec 12. pii: S1933-2874(19)30363-0. doi: 10.1016/j.jacl.2019.12.003. [Epub ahead of print]

PMID:
31917184
4.

Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.

Björnson E, Packard CJ, Adiels M, Andersson L, Matikainen N, Söderlund S, Kahri J, Hakkarainen A, Lundbom N, Lundbom J, Sihlbom C, Thorsell A, Zhou H, Taskinen MR, Borén J.

J Intern Med. 2019 Dec 17. doi: 10.1111/joim.13017. [Epub ahead of print]

PMID:
31846520
5.

Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.

Rank CU, Wolthers BO, Grell K, Albertsen BK, Frandsen TL, Overgaard UM, Toft N, Nielsen OJ, Wehner PS, Harila-Saari A, Heyman MM, Malmros J, Abrahamsson J, Norén-Nyström U, Tomaszewska-Toporska B, Lund B, Jarvis KB, Quist-Paulsen P, Vaitkevičienė GE, Griškevičius L, Taskinen M, Wartiovaara-Kautto U, Lepik K, Punab M, Jónsson ÓG, Schmiegelow K.

J Clin Oncol. 2020 Jan 10;38(2):145-154. doi: 10.1200/JCO.19.02208. Epub 2019 Nov 26.

PMID:
31770057
6.

A higher glycemic response to oral glucose is associated with higher plasma apolipoprotein C3 independently of BMI in healthy twins.

Bozzetto L, Berntzen BJ, Kaprio J, Rissanen A, Taskinen MR, Pietiläinen KH.

Nutr Metab Cardiovasc Dis. 2020 Mar 9;30(3):459-466. doi: 10.1016/j.numecd.2019.10.005. Epub 2019 Oct 15.

PMID:
31753785
7.

Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg doses.

Robinson JG, Farnier M, Kastelein JJP, Roth EM, Taskinen MR, Colhoun HM, Brunet A, DiCioccio AT, Lecorps G, Pordy R, Baccara-Dinet MT, Cannon CP.

J Clin Lipidol. 2019 Nov - Dec;13(6):979-988.e10. doi: 10.1016/j.jacl.2019.10.004. Epub 2019 Oct 14.

8.

The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia.

Banerjee J, Niinimäki R, Lähteenmäki P, Hed Myrberg I, Arola M, Riikonen P, Lönnqvist T, Palomäki M, Ranta S, Harila-Saari A, Taskinen M.

Pediatr Blood Cancer. 2020 Feb;67(2):e27999. doi: 10.1002/pbc.27999. Epub 2019 Nov 1.

PMID:
31674724
9.

Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the Svedberg flotation rate - Authors' response.

Björnson E, Packard CJ, Taskinen MR, Borén J.

J Intern Med. 2020 Jan;287(1):118. doi: 10.1111/joim.12997. Epub 2019 Nov 12. No abstract available.

PMID:
31631432
10.

Genetic architecture of human plasma lipidome and its link to cardiovascular disease.

Tabassum R, Rämö JT, Ripatti P, Koskela JT, Kurki M, Karjalainen J, Palta P, Hassan S, Nunez-Fontarnau J, Kiiskinen TTJ, Söderlund S, Matikainen N, Gerl MJ, Surma MA, Klose C, Stitziel NO, Laivuori H, Havulinna AS, Service SK, Salomaa V, Pirinen M; FinnGen Project, Jauhiainen M, Daly MJ, Freimer NB, Palotie A, Taskinen MR, Simons K, Ripatti S.

Nat Commun. 2019 Sep 24;10(1):4329. doi: 10.1038/s41467-019-11954-8.

11.

Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study.

Thastrup M, Marquart HV, Levinsen M, Grell K, Abrahamsson J, Albertsen BK, Frandsen TL, Harila-Saari A, Lähteenmäki PM, Niinimäki R, Pronk CJ, Ulvmoen A, Vaitkevičienė G, Taskinen M, Schmiegelow K; Nordic Society of Pediatric Hematology and Oncology (NOPHO).

Leukemia. 2020 Feb;34(2):336-346. doi: 10.1038/s41375-019-0570-1. Epub 2019 Sep 18.

PMID:
31534171
12.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group .

Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455. No abstract available.

PMID:
31504418
13.

Surgically treated ovarian lesions in preadolescent girls.

Ripatti L, Taskinen M, Koivusalo A, Taskinen S.

Acta Obstet Gynecol Scand. 2020 Jan;99(1):105-111. doi: 10.1111/aogs.13717. Epub 2019 Sep 6.

PMID:
31449329
14.

Dietary Fructose and the Metabolic Syndrome.

Taskinen MR, Packard CJ, Borén J.

Nutrients. 2019 Aug 22;11(9). pii: E1987. doi: 10.3390/nu11091987. Review.

15.

'Metaphyseal dysplasia without hypotrichosis' can present with late-onset extraskeletal manifestations.

Vakkilainen S, Costantini A, Taskinen M, Wartiovaara-Kautto U, Mäkitie O.

J Med Genet. 2020 Jan;57(1):18-22. doi: 10.1136/jmedgenet-2019-106131. Epub 2019 Aug 14.

16.

Childhood cancer mortality and survival in immigrants: A population-based registry study in Finland.

Kyrönlahti A, Madanat-Harjuoja L, Pitkäniemi J, Rantanen M, Malila N, Taskinen M.

Int J Cancer. 2019 Aug 13. doi: 10.1002/ijc.32625. [Epub ahead of print]

PMID:
31407318
17.

Viral infections and immune reconstitution interaction after pediatric allogenic hematopoietic stem cell transplantation.

Alexandersson A, Koskenvuo M, Tiderman A, Lääperi M, Huttunen P, Saarinen-Pihkala U, Anttila VJ, Lautenschlager I, Taskinen M.

Infect Dis (Lond). 2019 Oct;51(10):772-778. doi: 10.1080/23744235.2019.1650198. Epub 2019 Aug 5.

PMID:
31380705
18.

A 30-Year Prospective Follow-Up Study Reveals Risk Factors for Early Death in Cartilage-Hair Hypoplasia.

Vakkilainen S, Taskinen M, Klemetti P, Pukkala E, Mäkitie O.

Front Immunol. 2019 Jul 16;10:1581. doi: 10.3389/fimmu.2019.01581. eCollection 2019.

19.

Completeness of pediatric cancer registration in the Finnish Cancer Registry.

Jokela M, Leinonen MK, Malila N, Taskinen M, Madanat-Harjuoja LM.

Acta Oncol. 2019 Nov;58(11):1577-1580. doi: 10.1080/0284186X.2019.1638522. Epub 2019 Jul 10. No abstract available.

PMID:
31290361
20.

Suicides and deaths linked to risky health behavior in childhood cancer patients: A Nordic population-based register study.

Korhonen LM, Taskinen M, Rantanen M, Erdmann F, Winther JF, Bautz A, Feychting M, Mogensen H, Talbäck M, Malila N, Ryynänen H, Madanat-Harjuoja L.

Cancer. 2019 Oct 15;125(20):3631-3638. doi: 10.1002/cncr.32373. Epub 2019 Jul 9.

PMID:
31287570
21.

Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population-Ascertained Hyperlipidemias.

Rämö JT, Ripatti P, Tabassum R, Söderlund S, Matikainen N, Gerl MJ, Klose C, Surma MA, Stitziel NO, Havulinna AS, Pirinen M, Salomaa V, Freimer NB, Jauhiainen M, Palotie A, Taskinen MR, Simons K, Ripatti S.

J Am Heart Assoc. 2019 Jul 2;8(13):e012415. doi: 10.1161/JAHA.119.012415. Epub 2019 Jun 29.

22.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

23.

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.

Taskinen MR, Packard CJ, Borén J.

Curr Atheroscler Rep. 2019 May 20;21(8):27. doi: 10.1007/s11883-019-0791-9. Review.

24.

A nearly fatal primary Epstein-Barr virus infection associated with low NK-cell counts in a patient receiving azathioprine: a case report and review of literature.

Honkila M, Niinimäki R, Taskinen M, Kuismin O, Kettunen K, Saarela J, Turunen S, Renko M, Tapiainen T.

BMC Infect Dis. 2019 May 10;19(1):404. doi: 10.1186/s12879-019-4022-3. Review.

25.

Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia.

Adiels M, Taskinen MR, Björnson E, Andersson L, Matikainen N, Söderlund S, Kahri J, Hakkarainen A, Lundbom N, Sihlbom C, Thorsell A, Zhou H, Pietiläinen KH, Packard C, Borén J.

Diabetes Obes Metab. 2019 Aug;21(8):1861-1870. doi: 10.1111/dom.13744. Epub 2019 May 8.

PMID:
30972934
26.

Integrin signaling and mechanotransduction in regulation of somatic stem cells.

Isomursu A, Lerche M, Taskinen ME, Ivaska J, Peuhu E.

Exp Cell Res. 2019 May 15;378(2):217-225. doi: 10.1016/j.yexcr.2019.01.027. Epub 2019 Feb 25. Review.

PMID:
30817927
27.

Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics.

Björnson E, Packard CJ, Adiels M, Andersson L, Matikainen N, Söderlund S, Kahri J, Sihlbom C, Thorsell A, Zhou H, Taskinen MR, Borén J.

J Intern Med. 2019 May;285(5):562-577. doi: 10.1111/joim.12877. Epub 2019 Mar 12.

28.

Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.

Lim S, Taskinen MR, Borén J.

Obes Rev. 2019 Apr;20(4):599-611. doi: 10.1111/obr.12820. Epub 2018 Dec 27.

PMID:
30589487
29.

USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages.

Ruuth M, Soronen J, Kaiharju E, Merikanto K, Perttilä J, Metso J, Lee-Rueckert M, Taskinen MR, Kovanen PT, Öörni K, Olkkonen VM, Jauhiainen MS, Laurila PP.

Lipids Health Dis. 2018 Dec 13;17(1):285. doi: 10.1186/s12944-018-0930-2.

30.

A Wide Spectrum of Autoimmune Manifestations and Other Symptoms Suggesting Immune Dysregulation in Patients With Cartilage-Hair Hypoplasia.

Vakkilainen S, Mäkitie R, Klemetti P, Valta H, Taskinen M, Husebye ES, Mäkitie O.

Front Immunol. 2018 Oct 25;9:2468. doi: 10.3389/fimmu.2018.02468. eCollection 2018.

31.

Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome.

Lovric A, Granér M, Bjornson E, Arif M, Benfeitas R, Nyman K, Ståhlman M, Pentikäinen MO, Lundbom J, Hakkarainen A, Sirén R, Nieminen MS, Lundbom N, Lauerma K, Taskinen MR, Mardinoglu A, Boren J.

Sci Rep. 2018 Sep 21;8(1):14200. doi: 10.1038/s41598-018-31865-w.

32.

Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders.

Trotta L, Norberg A, Taskinen M, Béziat V, Degerman S, Wartiovaara-Kautto U, Välimaa H, Jahnukainen K, Casanova JL, Seppänen M, Saarela J, Koskenvuo M, Martelius T.

Orphanet J Rare Dis. 2018 Aug 17;13(1):139. doi: 10.1186/s13023-018-0864-9.

33.

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study.

Matikainen N, Söderlund S, Björnson E, Pietiläinen K, Hakkarainen A, Lundbom N, Taskinen MR, Borén J.

Diabetes Obes Metab. 2019 Jan;21(1):84-94. doi: 10.1111/dom.13487. Epub 2018 Sep 4.

34.

Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial.

Taskinen MR, Del Prato S, Bujas-Bobanovic M, Louie MJ, Letierce A, Thompson D, Colhoun HM.

Atherosclerosis. 2018 Sep;276:124-130. doi: 10.1016/j.atherosclerosis.2018.07.017. Epub 2018 Jul 21.

35.

Haematopoietic Stem Cell Transplantation in Children Shifts the Coagulation System towards a Pro-Coagulant State.

Långström S, Koskenvuo M, Huttunen P, Lassila R, Taskinen M, Ranta S, Heikinheimo M, Mäkipernaa A.

Thromb Haemost. 2018 Aug;118(8):1390-1396. doi: 10.1055/s-0038-1661394. Epub 2018 Jun 30.

PMID:
29960273
36.

Effect of Wilms tumor histology on response to neoadjuvant chemotherapy.

Taskinen S, Leskinen O, Lohi J, Koskenvuo M, Taskinen M.

J Pediatr Surg. 2019 Apr;54(4):771-774. doi: 10.1016/j.jpedsurg.2018.05.010. Epub 2018 May 19.

PMID:
29887169
37.

Impact of parental socioeconomic factors on childhood cancer mortality: a population-based registry study.

Tolkkinen A, Madanat-Harjuoja L, Taskinen M, Rantanen M, Malila N, Pitkäniemi J.

Acta Oncol. 2018 Nov;57(11):1547-1555. doi: 10.1080/0284186X.2018.1478125. Epub 2018 Jun 4.

PMID:
29863418
38.

Metabolic syndrome associates with left atrial dysfunction.

Nyman K, Granér M, Pentikäinen MO, Lundbom J, Hakkarainen A, Sirén R, Nieminen MS, Taskinen MR, Lundbom N, Lauerma K.

Nutr Metab Cardiovasc Dis. 2018 Jul;28(7):727-734. doi: 10.1016/j.numecd.2018.02.008. Epub 2018 Feb 21.

PMID:
29764718
39.

An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.

Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Räsänen SM, Lee S, Mancina RM, Bergentall M, Pietiläinen KH, Söderlund S, Matikainen N, Ståhlman M, Bergh PO, Adiels M, Piening BD, Granér M, Lundbom N, Williams KJ, Romeo S, Nielsen J, Snyder M, Uhlén M, Bergström G, Perkins R, Marschall HU, Bäckhed F, Taskinen MR, Borén J.

Cell Metab. 2018 Mar 6;27(3):559-571.e5. doi: 10.1016/j.cmet.2018.01.005. Epub 2018 Feb 15.

40.

ADA2 deficiency: Clonal lymphoproliferation in a subset of patients.

Trotta L, Martelius T, Siitonen T, Hautala T, Hämäläinen S, Juntti H, Taskinen M, Ilander M, Andersson EI, Zavialov A, Kaustio M, Keski-Filppula R, Hershfield M, Mustjoki S, Tapiainen T, Seppänen M, Saarela J.

J Allergy Clin Immunol. 2018 Apr;141(4):1534-1537.e8. doi: 10.1016/j.jaci.2018.01.012. Epub 2018 Jan 31. No abstract available.

PMID:
29391253
41.

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Monique Verschuren WM, Vlachopoulos C, Wood DA, Luis Zamorano J; Additional Contributor, Cooney MT.

Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):115. doi: 10.1016/j.rec.2017.01.002. English, Spanish. No abstract available.

PMID:
29389351
42.

Graft-versus-host disease in stem cell transplantation.

Taskinen M, Ryhänen S, Vettenranta K.

Duodecim. 2017;133(3):251-8. Review.

PMID:
29205023
43.

Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.

Banerjee JS, Heyman M, Palomäki M, Lähteenmäki P, Arola M, Riikonen PV, Möttönen MI, Lönnqvist T, Taskinen MH, Harila-Saari AH.

J Pediatr Hematol Oncol. 2018 Jan;40(1):e13-e18. doi: 10.1097/MPH.0000000000001009.

PMID:
29200159
44.

Evaluation of effect of preoperative chemotherapy on Wilms' tumor histopathology.

Taskinen S, Lohi J, Koskenvuo M, Taskinen M.

J Pediatr Surg. 2018 Aug;53(8):1611-1614. doi: 10.1016/j.jpedsurg.2017.10.002. Epub 2017 Oct 6.

PMID:
29074135
45.

Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.

Hashem H, Kumar AR, Müller I, Babor F, Bredius R, Dalal J, Hsu AP, Holland SM, Hickstein DD, Jolles S, Krance R, Sasa G, Taskinen M, Koskenvuo M, Saarela J, van Montfrans J, Wilson K, Bosch B, Moens L, Hershfield M, Meyts I; Deficiency of Adenosine Deaminase Type 2 Foundation.

Blood. 2017 Dec 14;130(24):2682-2688. doi: 10.1182/blood-2017-07-798660. Epub 2017 Oct 3.

46.

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

Leivonen SK, Taskinen M, Cervera A, Karjalainen-Lindsberg ML, Delabie J, Holte H, Lehtonen R, Hautaniemi S, Leppä S.

Blood Cancer J. 2017 Aug 25;7(8):e596. doi: 10.1038/bcj.2017.71.

47.

Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients.

Lähteenmäki K, Wacklin P, Taskinen M, Tuovinen E, Lohi O, Partanen J, Mättö J, Vettenranta K.

Bone Marrow Transplant. 2017 Oct;52(10):1479-1482. doi: 10.1038/bmt.2017.168. Epub 2017 Aug 7. No abstract available.

PMID:
28783141
48.

Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family.

Nikkola E, Ko A, Alvarez M, Cantor RM, Garske K, Kim E, Gee S, Rodriguez A, Muxel R, Matikainen N, Söderlund S, Motazacker MM, Borén J, Lamina C, Kronenberg F, Schneider WJ, Palotie A, Laakso M, Taskinen MR, Pajukanta P.

Atherosclerosis. 2017 Sep;264:58-66. doi: 10.1016/j.atherosclerosis.2017.07.024. Epub 2017 Jul 22.

49.

Diverse Autoantibody Reactivity in Cartilage-Hair Hypoplasia.

Biggs CM, Kostjukovits S, Dobbs K, Laakso S, Klemetti P, Valta H, Taskinen M, Mäkitie O, Notarangelo LD.

J Clin Immunol. 2017 Aug;37(6):508-510. doi: 10.1007/s10875-017-0408-4. Epub 2017 Jun 19. No abstract available.

50.

Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study.

Ong KL, O'Connell R, Januszewski AS, Jenkins AJ, Xu A, Sullivan DR, Barter PJ, Scott RS, Taskinen MR, Waldman B, Colman PG, Best JD, Simes JR, Rye KA, Keech AC; FIELD study investigators.

Clin Chem. 2017 Jul;63(7):1261-1270. doi: 10.1373/clinchem.2016.270876. Epub 2017 Jun 12.

PMID:
28606915

Supplemental Content

Loading ...
Support Center